Tandem Clinical Research

What Tandem Clinical Research does

Tandem Clinical Research is a Phase I-IV clinical trial site network that executes sponsored research protocols for pharmaceutical, biotechnology, and medical device companies. The company operates eight physical clinic locations across Louisiana (Marrero, Metairie, Covington, Houma), New Jersey (Freehold, Jackson, Somers Point), and Florida (Viera), with the Viera site identified as the most recent addition and the network collectively serving patient populations in the greater New Orleans, New York/New Jersey, and Orlando metropolitan areas. The team, led by board-certified physicians trained in Good Clinical Practice, has conducted more than 400 research trials across therapeutic areas including gastroenterology (with 150+ trials led by PI Dr. Adil Fatakia), hepatology (1,500+ liver biopsies and 250+ NASH/NAFLD enrollees via Dr. Gary Reiss), neurology and psychiatry (PI Dr. Angela Traylor), and geriatric/Alzheimer's research (PI Dr. Rosemary Laird). Patient services are provided free of charge, with compensation for time and travel; insurance is not billed, and all study-related costs are paid by the trial sponsor.

The core offering is direct clinical trial execution: patient recruitment, screening, informed consent, study conduct per protocol, source data collection, and regulatory compliance management. The supporting infrastructure includes online patient intake forms, condition-specific study pages covering 18+ indications, an active multi-channel marketing presence, and a healthcare provider referral program. The business model is professional-services based, with revenue derived from per-patient and per-protocol payments from sponsor companies; the company does not appear to monetize data, software, or platform access externally. Tandem operates as a subsidiary or affiliated entity of Prolerity Clinical Research Company, which provides apparent access to broader network resources, though no formal ownership percentages or financial terms are disclosed in the available data.

Customer segments split between pharmaceutical, biotechnology, and medical device companies seeking site-based trial execution (the B2B revenue side) and patients seeking access to investigational therapies (the demand side that drives enrollment). Strategic customers visible in the data include IGC Pharma, for whom Tandem activated a Metairie site in April 2026 for the Phase 2 CALMA trial in Alzheimer's disease agitation, and the company appears to also serve as a referring destination for a broader base of community healthcare providers. There are no disclosed funding rounds, revenue figures, or headcount growth data, and the company remains a privately held, for-profit entity operating with 11-50 total employees.

Name

Tandem Clinical Research

Legal name

Tandem Clinical Research

Website

https://tandemclinicalresearch.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Tandem Clinical Research operates an eight-site, multi-state Phase I-IV clinical trial network across Louisiana, New Jersey, and Florida, executing 400+ trials for pharmaceutical, biotech, and medical device sponsors across gastroenterology, neurology, hepatology, and CNS indications. All services are delivered free of charge to patients and paid by study sponsors.

Ownership category

akta.pro rank

Headquarters

HQ city

Marrero

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Sponsored Clinical Trials: Revenue generated from conducting clinical trials on behalf of pharmaceutical, biotech, and medical device companies. Services include patient enrollment, study conduct, data collection, and regulatory compliance. All medical services to patients are provided free of charge, with costs covered by study sponsors.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Tandem Clinical Research operates a multi-state Phase I-IV clinical trial site network that conducts studies for pharmaceutical, biotech, and medical device sponsors. Services include patient recruitment, screening, study conduct, data collection, and regulatory compliance delivered at physical clinic locations staffed by board-certified physicians across therapeutic areas such as gastroenterology, neurology, psychiatry, endocrinology, and metabolic disease. All medical services are provided free of charge to enrolled patients, with sponsor-funded trial execution as the underlying revenue model.

Product overview

Tandem Clinical Research is a dedicated Phase I-IV clinical trials network that operates as a single unified service offering rather than a platform-plus-modules architecture. The company provides clinical research services through a network of clinic locations in Louisiana (Marrero, Metairie, Covington, Houma), Florida (Viera-Melbourne), New Jersey (Freehold, Jackson, Somers Point), and New York. Their core offering consists of conducting clinical trials for pharmaceutical, biotech, and medical device companies, supported by patient intake and screening services, referring partner programs, and studies across multiple therapeutic areas including neurology, gastroenterology, metabolic disorders, and mental health. All medical services are provided free of charge by board-certified physicians. The company has conducted more than 400 research trials and is a Prolerity Clinical Research Company.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services (Phase I-IV) Full-service Phase I-IV clinical trial execution for pharmaceutical, biotech, and medical device sponsors, including study conduct, data collection, and regulatory compliance delivered by board-certified physician investigators across the network's clinic locations.
• Patient Intake and Screening Services Online intake form system that collects medical history, conditions, medications, and demographics to determine eligibility and prescreen candidates for active clinical trials.
• Therapeutic Area Studies Active and ongoing clinical trial programs across multiple therapeutic areas including Alzheimer's Disease, Asthma, Celiac Disease, Cirrhosis, Crohn's Disease, Depression, Diabetes, Eosinophilic Esophagitis, Gastroparesis, Migraine, Nonalcoholic Fatty Liver Disease, Obesity, Obstructive Sleep Apnea, Parkinson's Disease, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Schizophrenia, and Ulcerative Colitis.
• Referring Partner Program Partnership program for healthcare professionals, practices, community partners, social workers, dieticians, and caregivers to refer patients to clinical trials, including Lunch N Learn engagement opportunities.
• Multi-Site Clinical Research Network Physical site network of clinical trial clinics across Louisiana (Marrero, Metairie, Covington, Houma), New Jersey (Freehold, Jackson, Somers Point), Florida (Viera-Melbourne), and New York, serving the greater New Orleans, New York City, and Orlando areas.

Quantifiable outcome

• Over 400 research trials conducted
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• IGC PharmacoreStrategic or Co-development Partner · 7 April 2026IGC Pharma activated a new clinical trial site at Tandem Clinical Research in Metairie, Louisiana for the ongoing Phase 2 CALMA trial evaluating IGC-AD1 for agitation in Alzheimer's dementia. The trial enrollment reached over 70% completion with this expansion. The new site is led by Principal Investigator Dr. Angela Traylor, an experienced neurologist and psychiatrist.
• Prolerity Clinical ResearchcoreOthersTandem Clinical Research is identified as a Prolerity Clinical Research Company, indicating a parent-subsidiary or affiliated organizational relationship within the clinical research network.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PMG Research: PMG Research is an integrated network of clinical research sites specializing in multi-therapeutic Phase II-IV trials across the Southeastern and Mid-Atlantic U.S. Highly comparable to Tandem in operating model, therapeutic breadth, and sponsor relationships.
• Alliance for Multispecialty Research: Alliance for Multispecialty Research (AMR) is a network of clinical research sites operating across multiple U.S. states, conducting trials for pharma, biotech, and medical device sponsors in diverse therapeutic areas. Direct competitor with comparable multi-site, multi-therapeutic offering.
• Accel Research Sites: Accel Research Sites operates a network of fully integrated clinical research sites across the Southeast U.S., conducting trials across multiple therapeutic areas for pharmaceutical sponsors. Directly comparable multi-site SMO with overlapping geography and therapeutic mix.
• Centricity Research: Centricity Research (formerly IACT Health) is an integrated clinical research site network conducting Phase I-IV trials across a broad therapeutic footprint in the U.S. Highly comparable to Tandem in multi-site SMO model and sponsor relationships.
• Tekton Research: Tekton Research is a multi-site clinical research organization with locations across the U.S., focused on therapeutic-area specialization and patient recruitment for pharmaceutical trials. Operates the same dedicated Phase I-IV site-network model as Tandem.
• Velocity Clinical Research: Velocity Clinical Research is a large U.S. multi-site clinical research organization with 15+ integrated research sites across multiple states, conducting Phase I-IV trials for pharma and biotech sponsors. It directly competes with Tandem's multi-site SMO model, with deeper scale and a broader therapeutic footprint.

Broad incumbents

• Prolerity Clinical Research: Prolerity Clinical Research is Tandem's parent organization operating a broader network of affiliated clinical research site businesses. Comparable as the parent platform with wider therapeutic and geographic reach than Tandem alone.
• Labcorp Drug Development (Fortrea): Fortrea (post-Labcorp Drug Development spin-off) and Labcorp's clinical development services offer end-to-end CRO capabilities including site management and central lab services, competing with Tandem for sponsor contracts across Phase I-IV programs.
• IQVIA: IQVIA is the world's largest CRO with substantial site-network operations (IQVIA Prime Sites) and full-service clinical development capabilities. A broad incumbent that competes for the same pharma/biotech trial mandates at much greater scale.

Regional players

• ClinCloud Research: ClinCloud Research operates a Florida-based clinical research site in Viera, FL, which is also part of Tandem's network under Dr. Rosemary Laird. Directly comparable as a Florida site serving similar CNS/Alzheimer's trials for sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/clinicaltandem
• YouTubeyoutube.com/channel/UCs9Ca5y4fqWpZR0XvuLmNxQ
• Facebookfacebook.com/TandemClinicalResearch
• LinkedInlinkedin.com/company/tandem-clinical-research
• Instagraminstagram.com/tandemclinicalresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tandem Clinical Research